Publications for Renu Virmani, MD

  1. Alfieri O, Mayosi BM, Park SJ, Sarrafzadegan N, Virmani R. Exploring unknowns in cardiology. Nat Rev Cardiol.  2014 PubMed PMID:25245833
  2. Virmani R, Otsuka F, Prati F, Narula J, Joner M. Matching human pathology is essential for validating OCT imaging to detect high-risk plaques. Nat Rev Cardiol.  2014. PubMed PMID:25245830
  3. Sakakura K, Roth A, Ladich E, Shen K, Coleman L, Joner M, Virmani R. Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: a next-generation approach for treating sympathetic. EuroIntervention.  2014. PubMed PMID:25349043
  4. Sakakura K, Ladich E, Edelman ER, Markham P, Stanley JR, Keating J, Kolodgie FD, Virmani R, Joner M. Methodological Standardization for the Pre-Clinical Evaluation of Renal Sympathetic Denervation. JACC Cardiovasc Interv.  2014. PubMed PMID 25240550
  5. Mylotte D, Andalib A, Thriault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Transcatheter heart valve failure: a systematic review. Eur Heart J.  2014. PubMed PMID:25265974
  6. Kwak BR, Bck M, Bochaton-Piallat ML, Caligiuri G, Daemen MJ, Davies PF, Hoefer IE, Holvoet P, Jo H, Krams R, Lehoux S, Monaco C, Steffens S, Virmani R, Weber C, Wentzel JJ, Evans PC. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur Heart J.  2014. PubMed PMID:25230814
  7. Panikker S, Virmani R, Sakakura K, Kolodgie F, Francis DP, Markides V, Walcott G, McElderry HT, Wong T. Left atrial appendage electrical isolation and concomitant device occlusion: A safety and feasibility study with histologic characterization. Heart Rhythm.  2014. PubMed PMID 25239429
  8. Puchner SB, Ferencik M, Maurovich-Horvat P, Nakano M, Otsuka F, Kauczor HU, Virmani R, Hoffmann U, Schlett CL. Iterative image reconstruction algorithms in coronary CT angiography improve the detection of lipid-core plaque – a comparison with histology.  Eur Radiol.  2014 PubMed PMID:25182630
  9. Yahagi K, Joner M, Virmani R. Insights into very late stent thrombosis from the wisdom of pathology. J Invasive Cardiol.  2014. PubMed PMID:25198483
  10. Guagliumi G, Capodanno D, Saia F, Musumeci G, Tarantini G, Garbo R, Tumminello G, Sirbu V, Coccato M, Fineschi M, Trani C, De Benedictis M, Limbruno U, De Luca L, Niccoli G, Bezerra H, Ladich E, Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv.  2014. PubMed PMID:25129664
  11. Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR, Kolodgie FD, Virmani R, Joner M. natomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol.  2014. PubMed PMID:25125292
  12. Habib A, Karmali V, John MC, Polavarapu R, Nakazawa G, Pachura K, Davis T, Kolodgie FD, Virmani R, Finn AV. Everolimus-eluting stents improve vascular response in a diabetic animal model. Circ Cardiovasc Interv.  2014. PubMed PMID:24915972
  13. Sakakura K, Joner M, Virmani R. Does neointimal characterization following DES implantation predict long-term outcomes? JACC Cardiovasc Imaging.  2014 PubMed PMID:25124010
  14. Nakano M, Virmani R. Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice. Cardiovasc Interv Ther.  2014.  PubMed PMID:25074761
  15. Sen SK, Boelte KC, Barb JJ, Joehanes R, Zhao X, Cheng Q, Adams L, Teer JK, Accame DS, Chowdhury S, Singh LN; NISC Comparative Sequencing Program; CHARGE Consortium, Kavousi M, Peyser PA, Quigley L, Priel DL, Lau K, Kuhns DB, Yoshimura T, Johnson AD, Hwang SJ, et al. Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification. Am J Hum Genet.  2014.  PubMed PMID:24975946
  16. Virmani R, Joner M, Sakakura K. Recent highlights of ATVB: clarification. Arterioscler Thromb Vasc Biol.  2014 PubMed PMID:24876349
  17. Hsu S, Koren E, Chan Y, Koscec M, Sheehy A, Kolodgie F, Virmani R, Feder D. Effects of everolimus on macrophage-derived foam cell behavior. Cardiovasc Revasc Med.  2014 PubMed PMID:24972512
  18. Davidson LJ, Luna J, Virmani R, Asscher JA, Davidson CJ. First human experience of thermal arterial closure. Catheter Cardiovasc Interv.  2014 PubMed PMID:23934606
  19. Thiele JR, Habersberger J, Braig D, Schmidt Y, Goerendt K, Maurer V, Bannasch H, Scheichl A, Woollard KJ, von Dobschtz E, Kolodgie F, Virmani R, Stark GB, Peter K, Eisenhardt SU. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Circulation.  2014 PubMed PMID:24982116
  20. Sakakura K, Nakano M, Otsuka F, Yahagi K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R. Comparison of pathology of chronic total occlusion with and without coronary artery bypass graft. Eur Heart J.  2014 PubMed PMID:24126875
  21. Kar S, Hou D, Jones R, Werner D, Swanson L, Tischler B, Stein K, Huibregtse B, Ladich E, Kutys R, Virmani R. Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model .JACC Cardiovasc Interv.  2014 PubMed PMID:25060026
  22. Otsuka F, Joner M, Prati F, Virmani R, Narula J. Clinical classification of plaque morphology in coronary disease. Nat Rev Cardiol.  2014 PubMed PMID 24776706
  23. Nakano M, Yahagi K, Otsuka F, Sakakura K, Finn AV, Kutys R, Ladich E, Fowler DR, Joner M, Virmani R. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coll Cardiol.  2014 PubMed PMID:24768883
  24. Bentzon JF, Otsuka F, Virmani R, Falk E.  Mechanisms of plaque formation and rupture. Circ Res.  2014 PubMed PMID 24902970
  25. Pu J, Mintz GS, Biro S, Lee JB, Sum ST, Madden SP, Burke AP, Zhang P, He B, Goldstein JA, Stone GW, Muller JE, Virmani R, Maehara A. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol.  2014 PubMed PMID 24681142
  26. Otsuka F, Pacheco E, Perkins LE, Lane JP, Wang Q, Kamberi M, Frie M, Wang J, Sakakura K, Yahagi K, Ladich E, Rapoza RJ, Kolodgie FD, Virmani R. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model. Circ Cardiovasc Interv.  2014 PubMed PMID 24895447
  27. Yahagi K, Otsuka F, Sakakura K, Sanchez OD, Kutys R, Ladich E, Kolodgie FD, Virmani R, Joner M. Pathophysiology of superficial femoral artery in-stent restenosis. J Cardiovasc Surg (Torino).  2014 PubMed PMID:24755699
  28. Lane JP, Perkins LE, Sheehy AJ, Pacheco EJ, Frie MP, Lambert BJ, Rapoza RJ, Virmani R. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries. JACC Cardiovasc Interv.  2014 PubMed PMID:24835327
  29. Steigen SE, Holm NR, Butt N, Maeng M, Otsuka F, Virmani R, Ladich E, Steigen TK. Clinical use of optical coherence tomography to identify angiographic silent stent thrombosis.  Scand Cardiovasc J.  2014 PubMed PMID:24601754
  30. Sanchez OD, Sakakura K, Otsuka F, Yahagi K, Virmani R, Joner M. Expectations and limitations of contemporary intravascular imaging: lessons learned from pathology. Expert Rev Cardiovasc Ther.  2014. PubMed PMID:24738595
  31. Otsuka F, Sakakura K, Yahagi K, Joner M, Virmani R. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol.  2014 PubMed PMID:24558104
  32. Cooley BC, Nevado J, Mellad J, Yang D, St Hilaire C, Negro A, Fang F, Chen G, San H, Walts AD, Schwartzbeck RL, Taylor B, Lanzer JD, Wragg A, Elagha A, Beltran LE, Berry C, Feil R, Virmani R, Ladich E, Kovacic JC, Boehm M. TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.  Sci Transl Med.  2014 PubMed PMID:24622514
  33. Ladich E, Otsuka F, Virmani R. A pathologic study of explanted parachute devices from seven heart failure patients following percutaneous ventricular restoration. Catheter Cardiovasc Interv.  2014.  PubMed PMID 23703961
  34. Sheet D, Karamalis A, Eslami A, Nol P, Virmani R, Nakano M, Chatterjee J, Ray AK, Laine AF, Carlier SG, Navab N, Katouzian A. Hunting for necrosis in the shadows of intravascular ultrasound. Comput Med Imaging Graph.  2014 PubMed PMID 24035737
  35. Joner M, Virmani R. Glagov’s phenomenon: has our understanding of vascular remodeling changed?  Coron Artery Dis.  2014.  PubMed PMID 24492456
  36. Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z, Virmani R, Fuster V, Bosca L, Narula J. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat Med.  2014. PubMed PMID 24412923
  37. Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation.  2014 PubMed PMID 24163064
  38. Campbell IC, Suever JD, Timmins LH, Veneziani A, Vito RP, Virmani R, Oshinski JN, Taylor WR. Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in women.  PLoS One.  2014.  PubMed PMID:25365517
  39. Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F, Serruys PW, Virmani R, de Jaegere PP. Response to letter regarding article, Histopathology of embolic debris captured during transcatheter aortic valve replacement”.” Circulation.  2013.  PubMed PMID:24366596
  40. Campbell IC, Timmins LH, Giddens DP, Virmani R, Veneziani A, Rab ST, Samady H, McDaniel MC, Finn AV, Taylor WR, Oshinski JN. Computational Fluid Dynamics Simulations of Hemodynamics in Plaque Erosion.  Cardiovasc Eng Technol.  2013. PubMed PMID:24223678
  41. Otsuka F, Sakakura K, Virmani R. Are mast cells the real culprit in atherosclerosis? Eur Heart J.  2013 PubMed PMID 23832491
  42. Waksman R, Barbash IM, Chan R, Randolph P, Makuria AT, Virmani R. Beta radiation for renal nerve denervation: initial feasibility and safety. EuroIntervention.  2013.  PubMed PMID:24169134
  43. Tsukamoto K, Mani DR, Shi J, Zhang S, Haagensen DE, Otsuka F, Guan J, Smith JD, Weng W, Liao R, Kolodgie FD, Virmani R, Krieger M. Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.  Proc Natl Acad Sci U S A.  2013.  PubMed PMID:24082102
  44. Ali ZA, Roleder T, Narula J, Mohanty BD, Baber U, Kovacic JC, Mintz GS, Otsuka F, Pan S, Virmani R, Sharma SK, Moreno P, Kini AS. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv.  2013 PubMed PMID:24065447
  45. Schlett CL, Maurovich-Horvat P, Ferencik M, Alkadhi H, Stolzmann P, Scheffel H, Seifarth H, Nakano M, Do S, Vorpahl M, Kauczor HU, Bamberg F, Tearney GJ, Virmani R, Hoffmann U.  Histogram analysis of lipid-core plaques in coronary computed tomographic angiography: ex vivo validation against histology. Invest Radiol.  2013 PubMed PMID:23614976
  46. Dani S, Costa RA, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt S, Abizaid A. First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels – results. EuroIntervention.  2013 PubMed PMID23965355
  47. Yazdani SK, Sheehy A, Nakano M, Nakazawa G, Vorpahl M, Otsuka F, Donn RS, Perkins LE, Simonton CA, Kolodgie FD, Virmani R. Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents. J Invasive Cardiol.  2013 PubMed PMID:23913602
  48. Madder RD, Goldstein JA, Madden SP, Puri R, Wolski K, Hendricks M, Sum ST, Kini A, Sharma S, Rizik D, Brilakis ES, Shunk KA, Petersen J, Weisz G, Virmani R, Nicholls SJ, Maehara A, Mintz GS, Stone GW, Muller JE. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv.  2013 PubMed PMID:23871513
  49. Otsuka F, Yahagi K, Sakakura K, Virmani R. Why is the mammary artery so special and what protects it from atherosclerosis? Ann Cardiothorac Surg.  2013 PubMed PMID:23977631
  50. Singhal A, Arora G, Sajid A, Maji A, Bhat A, Virmani R, Upadhyay S, Nandicoori VK, Sengupta S, Singh Y. Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase. Sci Rep.  2013 PubMed PMID:23877358
  51. Nakano M, Otuska F, Yagahi K, Sakakura K, Kutys R, Ladich ER, Finn AV, Kolodgie FD, Virmani R.  Human autopsy study of drug-eluting stent restenosis:  histomorphological predictors and neointimal characteristics.  Eur Heart J. 2013 Jul 3.  Epub ahead of print.
  52. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK.  In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients with Acute Coronary Syndrome by Intravascular Optical Coherence Tomography.  J Am Coll Cardiol. 2013 Jun 26. doi:pii:S0735-1097(13)02524-2.  10.1016/j.jacc.2013.05.071 Epub ahead of print.
  53. Portanova A, Hakakian N, Mikulis DJ, Virmani R, Abdalla WM, Wasserman BA.  Intracranial vasa vasorum:  insights and implications for imaging.  Radiology. 2013 Jun;267(3):667-79.  doi:  10.1148/radio..13112310.
  54. Ladich E, Otsuka F, Virmani R.  A pathologic study of explanted parachute devices from seven heart failure patients following percutaneous ventricular restoration.  Catheter Cardiovasc Inter. 2013 May 22.  doi:  10.1022/ccd.25010.  Epub ahead of print.
  55. Yazdani SK, Pacheco E, Nakano M, Otsuka F, Naisbitt S, Kolodgie FD, Ladich E, Rousselle S, Virmani R.  Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model  Catheter Cardiovasc Inter. 2013.May 22.  doi:  10.1002/ccd.24995.  Epub ahead of print.
  56. Farooq V, Serruys PW, Heo JH, Gogas BD, Onuma Y, Perkins LE, Diletti R, Radu MD, Raber L, Bourantas CV, Zhang Y, van Remortel E, Pawar R, Rapoza RJ, Powers JC, van Beusekom HM, Garcia-Garcia HM, Virmani R.  Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model:  the potential implications for clinical practice.  JACC Cardiovasc Inter. 2013 May;6(5): 523-32.  doi:  10.1016/j.jcin.2012.12.131.
  57. Lemos PA, Farooq V, Takimura CK, Gutierrez PS, Virmani R, Kolodgie FD, Christians U, Kharlamov A, Doshi M, Sojitra P, van Beusekom HM, Serruys PW.  Emerging technologies:  polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.  EuroIntervention. 2013 May 20;9(1): 148-56.  Doi:  10.4244/EIJV9I1A21.
  58. Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML.  Biological responses in stented arteries.  Cardiovasc Res.2013 Jul.15;99(2):353-63. doi:  10.1093/cvr/cvt115. Epub 2013 May 10.
  59. Van Meighem MN, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otuska F, Serruys PW, Virmani R, de Jaegere PP.  Histopathology of embolic debris captured during Transcatheter aortic valve replacement.  Circulation.2013 Jun 4; 127(22):2191-201.  Doi:  10.1161/CIRCULATIONAHA.112.001091. Epub 2013 May 7.
  60. Otsuka F, Nakano M, Sakakura K, Ladich E, Kolodige FD, Virmani R.  Unique demands of the femoral anatomy and pathology and the need for unique interventions.  J Cardiovasc Surg (Torino). 2013 Apr;54(2):191-210.
  61. Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R.  Pathophysiology of atherosclerosis plaque progression.  Heart Lung Circ. 2013 Jun;22(6):  399-4111. Doi:  10.1016/j.hlc..2013.03.001.  Epub 2013 Mar 29.
  62. Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, Massberg S, Jehle J, Guagliumi G,. Kastrati A, Virmani R, Byrne RA, Joner M.  Tissue characterization after drug-eluting stent implantation using optical coherence tomography.  Arterioscler Thromb Vasc Bio.2013. Jun;33(6): 1376-83. doiL  10.1161/ATVBAHA.113.301227.  Epub 2013 Mar 28.
  63. Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL.  Oxidative stress and pathological changes after coronary artery interventions.  J Am Coll Cardiol. 2013 Apr 9;61(14):  1471-81 doi.:  10.1016/j.jacc.2012.11.068.
  64. Karolyi M, Seifarth H, Liew G, Schlett CL, Maurovich-Horvat P, Stolzmann P, Dai G, Huang S, Goergen CJ, Nakano M, Otsuka F, Virmani R, Hoffmann U Sosnovik DE.  Classification of coronary atherosclerotic plaques ex vivi with T1, T2, and ultrashort echo time CMR.  JACC Cardiovasc Imaging.2013 Apr;6(4):466-74. Doi:  10.1016/j.jcmg.2012.09.015 Epub 2013 Mar 14.
  65. Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, Malik S, Fuster V, Finn AV.  Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques.  J Am Coll Cardiol.2013 Mar 12:61(10):1041-51. Doi:  10.1016/j.jacc.2012.10.054.
  66. Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, DiVito L, Biondi-Zocccai, G, Halperin J, Fuster V, Ozaki Y, Narula J,.  OCT-based diagnosis and management of STEMI associated with intact fibrous cap.  JACC Cardiovasc Imagin.2013 Mar;6(3):283-7. Doi:  10.1016/j.jcmg.2012.12.007.
  67. Habib A, Karmali V, Polavarapu R, Akahori H, Nakano M, Yazdani S, Otuska F, Pachura K, Davis T, Narula J, Kolodgie DF, Virmani R, Finn AV.  Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.  J Am Coll Cardiol.2013 Mar 5; 61(9):971-80 doi:  10.1016/j.jacc.2011.12.018.
  68. Rathore S, Ball T, Nakano M, Kaplan A, Virmani R, Foerst J.  Circumferential strut fracture as a mechanism of “crush” bifurcation restenosis.  Am J Cardiol. 2013 Mar 1;111(5):770-3.  Doi: 10.1016/j.amjcard.2012.11.030. Epub 2013 Jan 2.
  69. Nieuwstadt HA, Akyildiz AC, Speelman L, Virmani R, van der Lugt A, van der Steen AF, Wentzel JJ, Gijsen FJ.  The influence of axial image resolution on atherosclerotic plaque stress computations.  J Biomech. 2013 Feb 22;46(4):689-95.  Doi 10.1016/j.biomech.2012.11.042.Epub 2012 Dec. 20
  70. Campbell IC, Weiss D, Suever JD, Virmani R, Veneziani A, Vito RP, Oshinski JN, Taylor WR. Biomechanical modeling and morphology analysis indicates plaque rupture due to mechanical failure unlikely in atherosclerosis-prone mice. Am J Physiol Heart Circ Physiol. 2013 Feb;304(3):H473-86. doi: 10.1152/ajpheart.00620.2012. Epub 2012 Nov 30
  71. Babcock DE, Hergenrother RW, Craig DA, Kolodgie FD, Virmani R. In vivo distribution of particulate matter from coated angioplasty balloon catheters.  Biomaterials. 2013 Jan 31. pii: S0142-9612(13)00056-2. doi: 10.1016/j.biomaterials.2013.01.040.
  72. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013 Jan 30. [Epub ahead of print]
  73. Najafi AH, Aghili N, Tilan JU, Andrews JA, Peng X, Lassance-Soares RM, Sood S, Alderman LO, Abe K, Li L, Kolodgie FD, Virmani R, Zukowska Z, Epstein SE, Burnett MS.  A new murine model of stress-induced complex atherosclerotic lesions. Dis Model Mech. 2013 Jan 11.
  74. van Dijk RA, Kolodgie F, Ravandi A, Leibundgut G, Hu PP, Prasad A, Mahmud E, Dennis E, Curtiss LK, Witztum JL, Wasserman BA, Otsuka F, Virmani R, Tsimikas S. Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. J Lipid Res. 2012 Dec;53(12):2773-90. doi: 10.1194/jlr.P030890. Epub 2012 Sep 11.
  75. Otsuka F, Finn AV, Virmani R. Do vulnerable and ruptured plaques hide in heavily calcified arteries? Atherosclerosis. 2013 Jan 9. doi:pii: S0021-9150(13)00005-1. 10.1016/j.atherosclerosis.2012.12.032.
  76. Rathore S, Ball T, Nakano M, Kaplan A, Virmani R, Foerst J. Circumferential Strut Fracture as a Mechanism of “Crush” Bifurcation Restenosis. Am J Cardiol. 2013 Jan 2. doi:pii: S0002-9149(12)02463-0. 10.1016/j.amjcard.2012.11.030. [Epub ahead of print]
  77. Nieuwstadt HA, Akyildiz AC, Speelman L, Virmani R, van der Lugt A, van der Steen AF, Wentzel JJ, Gijsen FJ. The influence of axial image resolution on atherosclerotic plaque stress computations. J Biomech. 2012 Dec 19. pii: S0021-9290(12)00694-X. doi: 10.1016/j.jbiomech.2012.11.042. [Epub ahead of print]
  78. Tao M, Yu P, Nguyen BT, Mizrahi B, Savion N, Kolodgie FD, Virmani R, Hao S, Ozaki CK, Schneiderman J. Locally applied leptin induces regional aortic wall degeneration preceding aneurysm formation in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):311-20. doi: 10.1161/ATVBAHA.112.300543. Epub 2012 Dec 6.
  79. Maurovich-Horvat P, Schlett CL, Alkadhi H, Nakano M, Otsuka F, Stolzmann P, Scheffel H, Ferencik M, Kriegel MF, Seifarth H, Virmani R, Hoffmann U. The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography. JACC Cardiovasc Imaging. 2012 Dec;5(12):1243-52. doi: 10.1016/j.jcmg.2012.03.019
  80. Otsuka F, Fuster V, Narula J, Virmani R. Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds. Mt Sinai J Med. 2012 Nov-Dec;79(6):641-53. doi: 10.1002/msj.21353.
  81. Maurovich-Horvat P, Schlett CL, Alkadhi H, Nakano M, Stolzmann P, Vorpahl M, Scheffel H, Tanaka A, Warger WC 2nd, Maehara A, Ma S, Kriegel MF, Kaple RK, Seifarth H, Bamberg F, Mintz GS, Tearney GJ, Virmani R, Hoffmann U. Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. Radiology. 2012 Nov;265(2):393-401. doi: 10.1148/radiol.12111891. Epub 2012 Sep 25.
  82. Otsuka F, Nakano M, Ladich E, Kolodgie FD, Virmani R. Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement. Thrombosis. 2012;2012:608593. doi: 10.1155/2012/608593. Epub 2012 Nov 21.
  83. Cheng Y, Yi G, Conditt GB, Sheehy A, Kolodgie FD, Tellez A, Polyakov I, Gu A, Aboodi MS, Wallace-Bradley D, Schuster M, Martens T, Itescu S, Kaluza GL, Basu S, Virmani R, Granada JF, Sherman W. Catheter-Based Endomyocardial Delivery of Mesenchymal Precursor Cells Using 3D Echo Guidance Improves Cardiac Function in a Chronic Myocardial Injury Ovine Model. Cell Transplant. 2012 Oct 25. [Epub ahead of print]
  84. Briguori C, Virmani R, Kolodgie F, Byrne RA, Steigerwald K, Orlowski M, Joner M. From bench to bedside: initial experience with the Primus drug-coated balloon catheter. Minerva Cardioangiol. 2012 Oct;60(5):507-15
  85. Schneiderman J, Schaefer K, Kolodgie FD, Savion N, Kotev-Emeth S, Dardik R, Simon AJ, Halak M, Pariente C, Engelberg I, Konstantinides S, Virmani R.  Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli. J Am Heart Assoc. 2012 Oct;1(5):e001727. doi: 10.1161/JAHA.112.001727. Epub 2012 Oct 25.
  86. Steigerwald K, Ballke S, Quee SC, Byrne RA, Vorpahl M, Vogeser M, Kolodgie F, Virmani R, Joner M. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation. EuroIntervention. 2012 Oct;8(6):752-9. doi: 10.4244/EIJV8I6A115.
  87. Zhao HQ, Nikanorov A, Virmani R, Schwartz LB.  Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.  Journal of Vascular Surgery.  2012 Jul 26.  Epub ahead of print
  88. Maldonado N, Kelly-Arnold A, Vengrenyuk Y, Laudier D, Fallon JT, Virmani R, Cardoso L, Weinbaum S.  A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability – potential implications for plaque rupture.  American Journal of Physiology Heart and Circulatory Physiology.  2012 Jul 9.  Epub ahead of print
  89. Kang SJ, Nakano M, Virmani R, Song HG, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.  OCT Findings in Patients with Recanalization of Organized Thrombi in Coronary Arteries.  JACC Cardiovascular Imaging. 2012 Jul;5(7);725-32
  90. Seifarth H, Schlett CL, Nakano M, Otsuka F, Karolyi M, Liew G, Maurovich-Horvat P, Alkadhi H, Virmani R, Hoffmann U.  Histopathological correlates of the napkin-ring sign plaque in coronary CT angiography. Atherosclerosis. 2012 Sep; 223 (1): 90-6.  Epub 2012 Jun 21.
  91. Yazdani SK, Farb A, Nakano M, Vorphal M, Ladich E, Finn AV, Kolodgie FD, Virmani R.  Pathology of Drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions.  JACC Cardiovascular Interventions 2012 Jun;5(6):666-74
  92. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y.  In-stent neoatherosclerosis:  a final common pathway of late stent failure.  Journal of American Cardiology.  2012 Jun 5;59(23):2051-7.
  93. Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R.  The importance of the endothelium in atherothrombosis and coronary stenting.  Nature Reviews Cardiology.  2012 May 22;9(8):439-53.
  94. Yazdani SK, Otsuka F, Nakano M, Finn AV, Virmani R.  Do animal models of vein graft atherosclerosis predict outcomes in man?  Atherosclerosis. 2012 Jul; 223 (1):  102-5.  Epub 2012 May 12.
  95. Finn AV, Saeed O, Virmani R.  Macrophage subsets in human atherosclerosis.  Circulation Research.  2012 Apr 27;110(9)
  96. Maehara A, Cristea E, Mintz GS, Lansky AJ, Dressler O, Biro S, Templin B, Virmani R, de Bruyne B, Serruys PW, Stone GW.  Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses.  JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S1-9.
  97. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudeck D, Falk E, Feldman MD, Fitzgerald P, Garcia H, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Räber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J, Siegel E, Sonada S, Suter M, Takarada S, Tanaka A, Terashima M, Troels T, Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G.  Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation.  J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72.
  98. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V.  Acute coronary events.  Circulation. 2012 Mar 6;125(9):1147-56.
  99. Foerst JR, Ball TC, Nakano M, Virmani R, Kaplan AV.  Late complication: xience v stent fractures with restenosis.  JACC Cardiovasc Interv. 2012 Feb;5(2):239-42.
  100. Yazdani SK, Kolodgie FD, Virmani R.  Ex vivo and preclinical assessment of    an endothelial progenitor cell capturing bioengineered stent.  Minerva Cardioangiol. 2012 Feb;60(1):11-22.
  101. Joner M, Cheng Q, Schönhofer-Merl S, Lopez M, Neubauer S, Mas-Moruno C, Laufer B, Kolodgie FD, Kessler H, Virmani R.  Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces.  J Biomed Mater Res B Appl Biomater. 2012 Apr;100(3):637-45.
  102. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, Ladich ER, Kolodgie FD, Virmani R.  Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging.  JACC Cardiovasc Imaging. 2012 Jan;5(1):71-82. 
  103. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, Ladich E, Lortkipanidze N, Matiashvili A, Valsecchi O, Virmani R, Stone GW.  Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.  JACC Cardiovasc Interv. 2012 Jan;5(1):12-20.
  104. Barbash IM, Saikus CE, Faranesh AZ, Ratnayaka K, Kocaturk O, Chen MY, Bell JA, Virmani R, Schenke WH, Hansen MS, Slack MC, Lederman RJ.  Direct percutaneous left ventricular access and port closure: pre-clinical feasibility.  JACC Cardiovasc Interv. 2011 Dec;4(12):1318-25.
  105. Mauriello A, Sangiorgi G, Virmani R, Servadei F, Trimarchi S, Holmes DR Jr, Kolodgie F, Biondi Zoccai G, Leuzzi C, Spagnoli LG.  Evidence of a topographical link between unstable carotid plaques and luminal stenosis: can we better stratify asymptomatic patients with significant plaque burden?  Int J Cardiol. 2012 Mar 8;155(2):309-11. Epub 2011 Dec 20.
  106. Nakano M, Otsuka F, Virmani R. Letter by Nakano et Al regarding article, “optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation”.  Circulation. 2011 Dec 20;124(25):e954; author reply e955.
  107. Franceschi F, Bonan R, Khairy P, Dubuc M, Thibault B, Macle L, Talajic M, Roy D, Koutbi L, Virmani R, Guerra PG.  Histopathological effects and evolution of transvenous β-radiation applications in right and left atria: an animal study. Europace. 2011 Dec 19. [Epub ahead of print]
  108. Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, Narula J, Kolodgie FD, Virmani R.  Hemoglobin Directs Macrophage Differentiation and Prevents Foam Cell Formation in Human Atherosclerotic Plaques.  J Am Coll Cardiol. 2011 Dec 7. [Epub ahead of print]
  109. Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Chan R, Su SH, Kolodgie F, VirmaniR.  In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.  Catheter Cardiovasc Interv. 2011 Nov 22. [Epub ahead of print]
  110. Xie H, Lucchesi L, Teach JS, Virmani R.  Long-term outcomes of a chitosan hemostatic dressing in laparoscopic partial nephrectomy.  J Biomed Mater Res B Appl Biomater. 2011 Nov 21.[Epub ahead of print]
  111. Killer-Oberpfalzer M, Aichholzer M, Weis S, Richling B, Jones R, Virmani R, Cruise GM.  Histological analysis of clipped human intracranial aneurysms and parent arteries with short-term follow-up.  Cardiovasc Pathol. 2011 Nov 17. [Epub ahead of print]
  112. Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, Rostad B, Pachura K, Adams L, Elliott J, Taylor WR, Narula J, Kolodgie F, Virmani R, Hong CC, Finn AV.  Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis.  Arterioscler Thromb Vasc Biol. 2011 Nov 17. [Epub ahead of print]
  113. Nakano M, Otsuka F, Finn AV, Virmani R.  Microvascular obstruction is caused by atherothrombosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention.  Circ Cardiovasc Imaging. 2011;4(6):597-600.
  114. Fefer P, Tsimikas S, Segev A, Sparkes J, Otsuma F, Kolodgie F, Virmani R, Juliano J, Charron T, Strauss BH.  The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.  Cardiovasc Revasc Med. 2011 Nov 11. [Epub ahead of print]
  115. Yazdani SK, Nakano M, Otsuka F, Kolodgie FD, Virmani R. In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent.  EuroIntervention. 2011;7(7):835-43.
  116. Granada JF, Milewski K, Zhao H, Stankus JJ, Tellez A, Aboodi MS, Kaluza GL, Krueger CG, Virmani R, Schwartz LB, Nikanorov A.  Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic Swine.  Circ Cardiovasc Interv. 2011;4(5):447-55.
  117. Guimaraes M, Uflacker R, Garretson JS, Vestal MC, Jones R, Virmani R, Cruise GM. Angiographic and histologic comparison of injectable, expansile hydrogel embolic and pushable AZUR embolic devices in porcine arteries.  J Vasc Interv Radiol. 2011;22(11):1619-1624.
  118. Nakano M, Vorpahl M, Otsuka F, Virmani R. Optical frequency domain imaging of stent fracture and coronary dissection associated with intraplaque hemorrhage.  JACC Cardiovasc Interv. 2011;4(9):1047-8.
  119. Ladich E, Nakano M, Carter-Monroe N, Virmani R. Pathology of calcific aortic stenosis.  Future Cardiol. 2011;7(5):629-42.
  120. Lee JB, Mintz GS, Lisauskas JB, Biro SG, Pu J, Sum ST, Madden SP, Burke AP, Goldstein J, Stone GW, Virmani R, Muller JE, Maehara A.  Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules.  Am J Cardiol. 2011;108(11):1547-51.
  121. Schipper ME, Stella PR, de Jonge N, Virmani R, de Weger RA, Vink A.  Embolization of hydrophilic coating material to small intracardial arteries after multiple percutaneous transluminal angioplasty procedures.  Int J Cardiol. 2011 Aug 16. [Epub ahead of print]
  122. Vorpahl M, Foerst JR, Kelm M, Kaplan AV, Virmani R, Ball T.  The complementary role of microCT and histopathology in characterizing the natural history of stented arteries. Expert Rev Cardiovasc Ther. 2011;9(7):939-48.
  123. Speelman L, Akyildiz AC, den Adel B, Wentzel JJ, van der Steen AF, Virmani R, van der Weerd L, Jukema JW, Poelmann RE, van Brummelen EH, Gijsen FJ.  Initial stress in biomechanical models of atherosclerotic plaques.  J Biomech. 2011;44(13):2376-82.
  124. Sheehy A, Hsu S, Sinn I, Tai J, Kolodgie FD, Nakazawa G, Yazdani SK, Quee SC, Virmani R, Polyakov I.  Vascular response to coronary artery stenting in mature and juvenile swine.  Cardiovasc Revasc Med. 2011;12(6):375-84.
  125. Larsen K, Cheng C, Tempel D, Parker S, Yazdani S, den Dekker WK, Houtgraaf JH, de Jong R, Swager-Ten Hoor S, Ligtenberg E, Hanson SR, Rowland S, Kolodgie F, Serruys PW, Virmani R, Duckers HJ. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.  Eur Heart J. 2011 Jul 6. [Epub ahead of print]
  126. Farooq V, Onuma Y, Radu M, Okamura T, Gomez-Lara J, Brugaletta S, Gogas BD, van Geuns RJ, Regar E, Schultz C, Windecker S, Lefèvre T, Brueren BR, Powers J, Perkins LL, Rapoza RJ, Virmani R, García-García HM, Serruys PW.  Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.  EuroIntervention. 2011;7(3):386-99.
  127. Milewski K, Tellez A, Aboodi MS, Conditt GB, Yi GH, Thim T, Stenoien M, McGregor JC, Gray WA, Virmani R, Granada JF, Kaluza GL.  Paclitaxel-iopromide coated balloon followed by “bail-out” bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.  EuroIntervention. 2011 Jul;7(3):362-8.
  128. Ozaki Y, Okumura M, Ismail TF, Motoyama S, Naruse H, Hattori K, Kawai H, Sarai M, Takagi Y, Ishii J, Anno H, Virmani R, Serruys PW, Narula J.  Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J. 2011;32(22):2814-23.
  129. Virmani R. Are our tools for the identification of TCFA ready and do we know them?  JACC Cardiovasc Imaging. 2011;4(6):656-8.
  130. Cutlip DE, Nakazawa G, Krucoff MW, Vorpahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R.  Autopsy validation study of the academic research consortium stent thrombosis definition.  JACC Cardiovasc Interv. 2011;4(5):554-9.
  131. Gogas BD, Radu M, Onuma Y, Perkins L, Powers JC, Gomez-Lara J, Farooq V, Garcia-Garcia HM, Diletti R, Rapoza R, Virmani R, Serruys PW.  Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies.  Int J Cardiovasc Imaging. 2011 Apr 19. [Epub ahead of print]
  132. Akyildiz AC, Speelman L, van Brummelen H, Gutiérrez MA, Virmani R, van der Lugt A, van der Steen AF, Wentzel JJ, Gijsen FJ.  Effects of intima stiffness and plaque morphology on peak cap stress.  Biomed Eng Online. 2011;10:25.
  133. Kappert U, Ouda A, Virmani R, Mettler D, Matschke K, Demertzis S.  The C-Port xV® vascular anastomosis system: results from an animal trial.  Thorac Cardiovasc Surg. 2011;59(4):222-6.
  134. Ladich E, Michaels MB, Jones RM, McDermott E, Coleman L, Komtebedde J, Glower D, Argenziano M, Feldman T, Nakano M, Virmani R; Endovascular Valve Edge-to-Edge Repair Study (EVEREST) Investigators. Pathological healing response of explanted MitraClip devices. Circulation. 2011;123(13):1418-27.
  135. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J. 2011;32(16):1977-85, 1985a, 1985b, 1985c.
  136. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57(11):1314-22.
  137. Egan MJ, Trask AJ, Baker PB, Lawrence J, Ladich E, Virmani R, Hill SL, Cheatham JP, Galantowicz M, Lucchesi PA, Kovalchin JP. Histopathologic evaluation of patent ductus arteriosus stents after hybrid stage I palliation. Pediatr Cardiol. 2011;32(4):413-7.
  138. Alfonso F, Virmani R.  New morphological insights on coronary plaque rupture: bridging the gap from anatomy to clinical presentation?  JACC Cardiovasc Interv. 2011;4(1):83-6
  139. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol. 2011;57(4):390-8.
  140. Qiao Y, Etesami M, Malhotra S, Astor BC, Virmani R, Kolodgie FD, Trout HH 3rd, Wasserman BA.  Identification of intraplaque hemorrhage on MR angiography images: a comparison of contrast-enhanced mask and time-of-flight techniques.  AJNR Am J Neuroradiol. 2011 Mar;32(3):454-9.
  141. Nakazawa G, Nakano M, Otsuka F, Wilcox JN, Melder R, Pruitt S, Kolodgie FD, Virmani R. Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis. Circ Cardiovasc Interv. 2011;4(1):38-46.
  142. Carter-Monroe N, Virmani R. Current trends in the classification of sudden cardiac death based on autopsy derived data: a review of investigations into the etiology of sudden cardiac death.  Rev Esp Cardiol. 2011;64(1):10-2.
  143. Yazdani SK, Nakano M, Otsuka F, Kolodgie FD, Virmani R.  Atheroma and coronary bifurcations: before and after stenting.  EuroIntervention. 2010;6 Suppl J:J24-30.
  144. Vorpahl M, Yazdani SK, Nakano M, Ladich E, Kolodgie FD, Finn AV, Virmani R.  Pathobiology of stent thrombosis after drug-eluting stent implantation. Curr Pharm Des. 2010;16(36):4064-71.
  145. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation. 2010;122(24):2505-13.
  146. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, García-García HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010;122(22):2288-300.
  147. Yazdani SK, Vorpahl M, Ladich E, Virmani R.  Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke.  Curr Treat Options Cardiovasc Med. 2010;12(3):297-314.
  148. Killer M, Kallmes D, Jones R, Ding Y, Vestal M, Hauser T, Virmani R, Cruise G.  Long-term angiographic and histological results of a new hydrogel-containing filling coil in experimental rabbit aneurysms.  Minim Invasive Neurosurg. 2010;53(3):97-105.
  149. Angeli FS, Amabile N, Shapiro M, Mirsky R, Bartlett L, Zhang Y, Virmani R, Chatterjee K, Boyle A, Grossman W, Yeghiazarians Y.  Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.  Cardiovasc Drugs Ther. 2010;24(5-6):409-20.
  150. Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, Erdos MR, Blair C, Funke B, Smoot L, Gerhard-Herman M, Machan JT, Kutys R, Virmani R, Collins FS, Wight TN, Nabel EG, Gordon LB.  Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging.  Arterioscler Thromb Vasc Biol. 2010;30(11):2301-9.Schwartz RS, Holmes DR, Van Tassel RA, Hauser R, Henry TD, Mooney M, Matthews R, Doshi S, Jones RM, Virmani R. Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc Interv. 2010;3(8):870-7.
  151. Donnelly P, Maurovich-Horvat P, Vorpahl M, Nakano M, Kaple RK, Warger W, Tanaka A, Tearney G, Virmani R, Hoffmann U.  Multimodality imaging atlas of coronary atherosclerosis.  JACC Cardiovasc Imaging. 2010;3(8):876-80.
  152. Finn AV, Kolodgie FD, Nakano M, Virmani R. The differences between neovascularization of chronic total occlusion and intraplaque angiogenesis. JACC Cardiovasc Imaging. 2010;3(8):806-10.
  153. Carter-Monroe N, Ladich E, Virmani R, Kolodgie FD.  Histopathologic assessment of myocardial regeneration. Methods Mol Biol. 2010;660:125-48.
  154. Angeli FS, Smith C, Amabile N, Shapiro M, Bartlett L, Virmani R, Chatterjee K, Boyle A, Grossman W, Yeghiazarians Y.  Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction. J Card Fail. 2010;16(7):579-89.
  155. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R.  Concept of vulnerable/unstable plaque.  Arterioscler Thromb Vasc Biol. 2010;30(7):1282-92.
  156. Jilaihawi H, Virmani R, Nakagawa H, Ducharme A, Shi YF, Carter-Monroe N, Ladich E, Iyer M, Ikeda A, Asgar A, Bonan R.  Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device.  EuroIntervention. 2010;6(1):54-62.
  157. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, Tahara N, Fuster V, Warburton EA, Fayad ZA, Tawakol AA.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?  J Am Coll Cardiol. 2010;55(23):2527-35.
  158. Lombardini ED, Virmani R, Blanchard TW, Lafond JF, Ménard S, Doré M.  Epithelioid hemangioendothelioma in the right auricle of an adult, male Rhesus macaque (Macaca mulatta). J Med Primatol. 2010;39(5):315-7.
  159. Granada JF, Inami S, Aboodi MS, Tellez A, Milewski K, Wallace-Bradley D, Parker S, Rowland S, Nakazawa G, Vorpahl M, Kolodgie FD, Kaluza GL, Leon MB, Virmani R. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix.  Circ Cardiovasc Interv. 2010;3(3):257-66.
  160. Waxman S, Freilich MI, Suter MJ, Shishkov M, Bilazarian S, Virmani R, Bouma BE, Tearney GJ.  A case of lipid core plaque progression and rupture at the edge of a coronary stent: elucidating the mechanisms of drug-eluting stent failure.  Circ Cardiovasc Interv. 2010;3(2):193-6.
  161. Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, Christians U, Betts R, Savage D, Su SH, Shulze J, Kar S.  Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.  Circ Cardiovasc Interv. 2010;3(2):174-83.
  162. Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R, Alkadhi H.  The napkin-ring sign: CT signature of high-risk coronary plaques?  JACC Cardiovasc Imaging. 2010;3(4):440-4.
  163. Nakazawa G, Granada JF, Alviar CL, Tellez A, Kaluza GL, Guilhermier MY, Parker S, Rowland SM, Kolodgie FD, Leon MB, Virmani R. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.  JACC Cardiovasc Interv. 2010;3(1):68-75.
  164. Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A, Coleman L, Perkins L, Nakazawa G, Mintz G, Kaluza GL, Virmani R, Granada JF.  Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.  JACC Cardiovasc Imaging. 2010;3(1):76-84.
  165. van Dijk RA, Virmani R, von der Thüsen JH, Schaapherder AF, Lindeman JH.  The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region.  Atherosclerosis. 2010;210(1):100-6.
  166. Finn AV, Vorpahl M, Ladich E, Virmani R.  Future directions in stenting.  Expert Rev Cardiovasc Ther. 2010;8(1):1-6.
  167. Kramer MC, Rittersma SZ, de Winter RJ, Ladich ER, Fowler DR, Liang YH, Kutys R, Carter-Monroe N, Kolodgie FD, van der Wal AC, Virmani R. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol, 2010;55(2):122-32.
  168. Mauriello, A, Sangiorgi, GM, Virmani R, Trimarchi S, Holmes DR Jr, Kolodgie FK, Piepgras G, Liotti D, Narula J, Righini P, Ippoliti A, Spagnoli LG.A Pathobiologic Link Between Risk Factors Profile and Morphological Markers of Carotid Instability. Atherosclerosis, 2010;208:572-580.
  169. Chin-Quee SL, Hsu SH, Nguyen-Ehrenreich KL, Tai JT, Abraham GM, Pacetti SD, Chan YF, Nakazawa G, Kolodgie FD, Virmani R, Ding NN, Coleman LA. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings. Biomaterials, 2010;31:648-657.
  170. Vorpahl M, Finn AV, Nakano M, Virmani R.  Vascular remodeling after coronary stent implantation.  Minerva Cardioangiol. 2009;57(5):621-8.
  171. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R.  Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.  J Am Coll Cardiol. 54(21):1924-31.
  172. Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, Virmani R.   Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology.  J Am Coll Cardiol., 2009;54(23):2167-73.
  173. Finn AV, John M, Nakazawa G, Polavarapu R, Karmali V, Xu X, Cheng Q, Davis T, Raghunathan C, Acampado E, Ezell T, Lajoie S, Eppihimer M, Kolodgie FD, Virmani R, Gold HK.  Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.  Circ Res., 2009;105(10):1003-12.
  174. Pop-Busui, Lu J, Lopes N, Jones TLZ, and the BARI 2D Investigators. Prevalence of Diabetic Peripheral Neuropathy and Relation to Glycemic Cntrol Therapies at Basline in the BARI 2D Cohort. Journal of the Peripheral Nervous System 2009;14:1-13.
  175. The BARI 2D Study Group. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. The New England Journal of Medicine, 2009;360:2503-15.
  176. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Picler WJ, Juni P, Virmani R, Windecker S. Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Euting Stent Thrombosis. Circulation. 2009;120:391-399.
  177. Fu Z, Wang M, Gucek M, Zhang J, Wu J, Jiang L, Monticone RE, Khazan B, Tekkjohann R, Mattison J, Sheng S, Cole RN, Spinetti G, Pintus G, Liu L, Kolodgie FD, Virmani R, Spurgeon H, Ingram DK, Everett AD, Lakatta EG, Van Eyk JE. Milk Fat Globule Protein Epidermal Growth Factor-8: A Pivotal Relay Element Within the Angiotension II and Monocyte Chemoattractant Protein-1 Signaling Cascade Mediating Vascular Smooth Muscle Cells Invasion. Circulation Research 2009;104;1337-1346.
  178. Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R. Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries. Circulation 2009;120:141-149.
  179. Zhao HQ, Nikanorov A, Virmani R, Jones R, Pacheco E, Schwartz LB. Late Stent Expansion and Neointimal Proliferation of Oversized Nitinol Stents in Peripheral Arteries. Cardiovasc Interventional Radiology, 2009;32:720-726.
  180. Waksman R, Baffour R, Pakala R, Scheinowitz M, Hellinga D, Seabron R, Chan R, Kolodige FD, Virmani R. Effects of Exogenous Peripheral-blood-derived Endothelial Progenitor Cells or Unfractionated Bone-marrow-derived Cells on Neonintimal Formation and Inflammation in Cholesterol-fed, Balloon-denuded, and Radiated Iliac Arteries of Inbred Rabbits. Cardiovascular Revascularization Medicine, 2009;10;110-116.
  181. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, Naruse H, Ishii J, Hishida H, Wong ND, Virmani R. Kondo T, Ozaki Y, Narula J. Computed Tomographic Angiography Characteristics of Atherosclerotic Plaques Subsequently Resulting in Acute Coronary Syndrome. Journal of the American College of Cardiology, 2009;54:49-57.
  182. Finn AV, Kramer MCA, Vorpahl M, Kolodgie FD, Virmani R. Pharmacotherapy of coronary atherosclerosis. Expert Opinion in Pharmacotherapy, 2009 10(10):1587-1603.
  183. Sluimer JC, Kolodgie FD, Bijnens APJJ, Maxfield K, Pacheco E, Kutys B, Duimel H, Frederik PM, van Hinsbergh VWN, Virmani R, Daemen MJAP. Thin-Walled Microvessels in Human Coronary Atheroscerotic Plaques Show Incomplete Endothelial Junctions. Journal of the American College of Cardiology 2009;53:1517-27.
  184. Nakazawa G, Finn AV, Kolodgie FD, Virmani R. A review of current devices and a look at new technology: drug-eluting stents. Expert Review of Medical Devices, 2009 Jan;6(1):33-42.
  185. Virmani R, Finn AV, Kolodgie FD. Carotid plaque stabilization and progression after stroke or TIA. Arterioscler. Thromb. Vasc. Biol. 2009;29;3-6.
  186. Tahara N, Imaizumi T, Virmani R, Narula J. Clinical Feasibility of Molecular Imaging of Plaque Inflammation in Atherosclerosis. Journal of Nuclear Medicine 2009:50:331-334.
  187. Hara H, Virmani R, Holmes D Jr, Buchbinder M, Lesser JR, Van Tassel RA, Mooney MR, Schwartz RS. Valvular and Structural Heart Disease; Is the Left Atrial Appendage More Than a Simple Appendage? Catheterization and Cardiovascular Interventions, Published Online: 8Jan 2009
  188. Kanjwal K, Haller S, Steffes M, Virmani R, Shapiro JI, Burket MW, Cooper CJ, Colyer WR Jr. Complete Versus Partial Distal Embolic Protection During Renal Artery Stenting. Catherterization and Cardiovascular Interventions, 2009; 73:725-730
  189. Burke A, Jeudy J Jr, Virmani R. Cardiac Tumours: an Update. Heart, 2008;94:117-123.
  190. Nakazawa G, Ladich E, Finn AV, Virmani R. Pathophysiology of vascular healing and stent mediated arterial injury. EuroInternention Suppliment (2008) Vol. 4 (Suppliment C) C7-C10.
  191. Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, Kolodgie FD, Virmani R. Drug-eluting stent safety: findings from pre-clinical studies. Expert Rev Cardiolvasc Ther. 2008 Nov;6(10):1379-91.
  192. Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL, Conneely KN, Qu X, San H, Ganesh SK, Chen X, Avallone H, Kolodgie FD, Virmani R. A famesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci USA. 2008 Oct 14;105(41):15902-7.
  193. Waksman R, McEwan PE, Moore TI, Pakala R, Kolodgie FD, Hellinga DG, Seabron RC, Rychnovsky SJ, Vasek J, Scott RW, Virmani R. PhotoPoint photodynamic therapy promotes stabilization of atherosclerostic plaques and inhibits plaque progression. J Am Coll Cardiol 2008;52:1024-32.
  194. Lanzer P, Sternberg K, Schmitz KP, Kolodgie F, Nakazawa G, Virmani R. Drug-eluting coronary stent very late thrombosis revisited. Herz. 2008 Jul;33(5):334-342.
  195. Gardner C, Tan H, Hull E, Lisauskas J, Sum S, Meese T, Jiang C, Madden S, Caplan J, Burke A, Virmani R, Goldstein J, Muller J. Detection of Lipid Core Coronary Plaques in Autopsy Specimens With a Novel Catheter-Based Near-Infrared Spectroscopy System. J. Am. Coll. Cardiol. Img. 2008; 1;638-648.
  196. Nakazawa G, Finn A, Joner M, Ladich E, Kutys R, Mont E, Gold H, Burke A, Kolodgie F, Virmani, R. Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluding Stent Placement for Acute Myocardial Infarction Patients. Interventional Cardiology 2008
  197. Joner M, Morimoto K, Kasukawa H, Steigerwald K, Merl S, Nakazawa G, John MC, Finn AV, Acampado E, Kolodgie FD, Gold HK, Virmani R. Site-Specific Targeting of Nanoparticle Prednisolone Reduces In-Stent Restenosis in a Rabbit Model of Established Atheroma. Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1960-6.
  198. Killingsworth CR, Rippy MK, Virmani R, Rollins D, McGiffin DC, Ideker RE. Evaluation of a Novel Ventricular Support Device with Defibrillation Capabilities in Canine and Porcine Animal Models. J Cardiovasc Electophysiol, 2008 Aug;19:851-857.
  199. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008 Jul 29;52(5):333-42.
  200. Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med. 2008 Aug;5 Suppl 2:S2-10.
  201. Xu C, Schmitt JM, Carlier SG, Virmani R. Characterization of atherosclerosis plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography. J Biomed Opt. 2008 May-Jun;13(3):034003.
  202. John MC, Wessely R, Kastrati A, Schomig, A, Joner M, Uchihashi M, Crimins J, Lajoie S, Kolodgie FD, Gold HK, Virmani R. Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents. JACC Cardiovascular Interventions. 2008;1:535-44.
  203. Sanghi P, Virmani R, Do D, Erikson J, Elliott J. Cilingiroglu M, Matthews H, Kazi M, Ricker R, Bailey SR. A comparative evaluation of arterial blood flow and the healing response after femoral artery closure using angio-seal STS Plus and StarClose in a porcine model. J Interv Cardiol. 2008 Aug:21(4):329-36.
  204. Ishii Y, Sakamoto S, Kronengold RT, Virmani R, Rivera EA, Goldman SM, Prechtel EJ, Hill JG, Damiano RJ Jr. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J Thorac Cardiovasc Surg. 2008 Jun;135(6):1237-45; discussion 1245-6.
  205. Cooper CJ, Haller ST, Colyer W. Steffes M, Burket MW, Thomas WJ, Safian R, Reddy B, Brewster P, Ankenbrandt MA, Virmani R, Dippel E, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapiro JI, D’Angostino RD, Pencina MJ, Khuder S.  Circulation. 2008 May 27;117(21):2752-60.
  206. Burke A, Virmani R. Pediatric heart tumors. Cardiovasc Pathol. 2008 Jul-Aug;17(4):193-8.
  207. Tavora F, Burke A, Kutys R, Li L, Virmani R. Total anomalous origin of the coronary circulation from the right pulmonary artery. Cardiovasc Pathol. 2008 Jul-Aug;17(4):246-9.
  208. Lim WS, Timmins JM, Seimon TA, Sadler A, Kolodgie FD, Virmani R, Tabas I.  Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation. 2008;117(7):940-51.
  209. Burke AP, Tavora F, Narula N, Tomaszewski JE, Virmani R. Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification. Hum Pathol. 2008;39(4):514-26.
  210. Joner M, Nakazawa G, Finn AV, Chin Quee S, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu S, Gold HK, Kolodgie FD, Virmani R. Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents. J Am Coll Cardiol 2008;52:333-42.
  211. Konig A, Margolis MP, Virmani R, Holmes D, Klauss V: Medscape. Technology insight: in vivo coronary plaque classification by intravascular ultrasonography radiofrequency analysis. Nat Clin Pract Cardiovasc Med. 2008 Apr;5(4):219-29.
  212. Waksman R, Pakala R, Roy P, Baffour R, Hellinga D, Seabron R, Chan R, Scheinowitz M, Kolodgie F, Virmani R. Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries. J Interv Cardiol. 2008 Apr; 21(2):122-8.
  213. Tavora F, Burke A, Li L, Franks TJ, Virmani R. Postmortem confirmation of Lyme carditis with polymerase chain reaction. Cardiovasc Pathol. 2008 Mar-Apr;17(2):103-7.
  214. Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, Safian R, Reddy B, Brewster P, Ankenbrandt MA, Virmani R, Dippel E, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapir JE, D’Agostino RD, Pencina MJ, Khuder S. Embolic Protection and Platelet Inhibition During Renal Artery Stenting. Circulation, 2008;117:2752-2760.
  215. Nakazawa G, Cheng Q, Xu X, Finn AV, Kolodgie FD, Virmani R. Drug-eluting stent implantation may not affect vasomotor function in early phase. J Am Coll Cardiol. 2008 Mar 18;51(11):1124-5.
  216. Nasu K, Tsuchikane E, Katoh O, Vince DG, Margolis PM, Virmani R, Surmely JF, Ehara M, Kinoshita Y, Fujita H, Kimura M, Asakura K, Matsubara T, Terashima M, Suzuki T. Impact of intramural thrombus in coronary arteries on the accuracy of tissue characterization by in vivo intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2008 Apr 15;101(8):1079-83.
  217. Killingsworth CR, Rippy MK, Virmani R, Rollins DL, McGiffin DC, Ideker RE. Evaluation of a novel ventricular support device with defibrillation capabilities in canine and porcine animal models. J Cardiovasc Electrophysiol. 2008 Aug;19(8):851-7.
  218. Hara H, Matthews R, Virmani R, Holmes D, Schwartz S. Percutaneous Left Atrial Appendage Obliteration. J Am Coll Cardiol Img. 2008;1:92-93.
  219. Nakazawa G, Finn AV, Virmani R. Drug-eluting stent pathology – should we still be cautious? Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):1.
  220. Burke A, Jeudy J Jr, Virmani R. Cardiac tumors: an update. Heart. 2008 Jan;94(1):117-23.
  221. Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, Young R, Rippy MK, Virmani R, Litt H, Wilensky RL. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J. 2008 Jan;29(2):251-9.
  222. Sarai M, Hartung D, Petrov A, Zhou J, Narula N, Hofstra L, Kolodgie F, Isobe S, Fujimoto S, Vanderheyden JL, Virmani R, Reutelingsperger C, Wong ND, Gupta S, Narula J. Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging. J Am Coll Cardiol. 2007 Dec 11;50(24):2305-12.
  223. Finn AV, Nakazawa G, Narula J, Virmani R.  Culprit plaque in myocardial infarction going beyond angiography.  J Am Coll Cardiol. 2007;50(23):   2204-6.
  224. Waksman R, Pakala R, Baffour R, Hellinga D, Seabron R, Tio FO, Wittchow E, Tittelbach M, Diener T, Harder C, Virmani R, Jones R. Efficacy and safety of pimecrolimus-eluting stents in porcine coronary arteries. Cardiovasc Revasc Med. 2007 0ct-Dec;8(4):259-74.
  225. Nakazawa G, Finn A, John M, Kolodgie F, Virmani R. The significance of pre-clinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. Am J Cardiol. 2007;100(8B):36M-44M.
  226. Cooper L, Baughman K, Feldman A, Frustaci A, Jessup M, Kuhl U, Levine G, Narula J, Starling R, Towbin J, Virmani R, American Heart Association, American College of Cardiology, European Society of Cardiology, Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2007;116(19):2216-33.
  227. Hartung D, Petrov A, Haider N, Fujimoto S, Blankenberg F, Fujimoto A, Virmani R, Kolodgie F, Strauss H, Narula J. Radiolabeled Monocyte Chemotactic Protein 1 for the detection of inflammation in experimental atherosclerosis. J Nucl Med. 2007;48(11):1816-21.
  228. Diethrich E, Pauliina Margolis M, Reid D, Burke A, Ramaiah V, Rodriguez-Lopez J, Wheatley G, Olsen D, Virmani R. Virtual histology intravascular ultrasound assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J Endovasc Ther. 2007;14(5): 676-86.
  229. Kolodgie F, Burke A, Nakazawa G, Cheng Q, Xu X, Virmani R. Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol. 2007;18(5):500-7.
  230. Ribichini F, Pugno F, Ferrero V, Wijns W, Vacca G, Vassanelli C, Virmani R. Long-term histologic and immunohistochemic findings in human venous aorto-coronary bypass grafts. Clin Sci. 2007.
  231. Kolodgie F, Nakazawa G, Sangiorgi G, Ladich E, Burke A, Virmani R. Pathology of atherosclerosis and stenting. Neuroimaging Clin N Am. 2007;17(3):285-301
  232. Jain RK, Finn A, Kolodgie F, Virmani R. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med. 2007;4(9):491-502.
  233. Finn, A, Nakazawa G, Kolodgie F, Virmani R. Controversies surrounding the use of drug-eluting stents. Am Heart Hosp J. 2007;5:141-145.
  234. Burke A, Virmani R. Pathophysiology of acute myocardial infarction. Med Clin North Am. 2007 Jul;91(4):553-72.
  235. Nakazawa G, Finn A, Virmani R. Vascular pathology of drug-eluting stents.  Herz. 2007;32:274-800.
  236. Finn A, Joner M, Nakazawa G, Kolodgie F, Newell J, John M, Gold H, and Virmani R. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation. 2007;115:2435-2441.
  237. Finn A, Nakazawa G, Joner M, Kolodgie F, Mont E, Gold H and Virmani R.    Vascular responses to drug-eluting stents, importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500-1510.
  238. Luscher T, Steffel J, Eberli F, Joner M, Nakazawa G, Tanner F and Virmani R.  Drug-eluting stent and coronary thrombosis: biological mechanism and clinical implications. Circulation. 2007;115:1051-1058.
  239. Kolodgie F, Narula J, Yuan C, Burke A, Finn A, Virmani R. Elimination of   neoangiogenesis for plaque stabilization, Is there a role for local drug therapy? J Am Coll Cardiol. 2007;49:2093-101.
  240. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus JL, Karnicki K, Stewart M, Pelzel JM, Schwartz RS. Patent Foramen Ovale: Standards for a Pre-clinical Model of Prevalence, Structure, and Histopathologic Comparability to Human Hearts. Catheterization and Cardiovascular Interventions. 2007 Feb;69(2):266-73.
  241. Joner M, Farb A, Cheng Q, Finn A, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie F, Gold HK, Virmani R. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-β and MCP-1. Arterioscler Thromb Vasc Biol. 2007;27:182-189.
  242. Fischell TA, Fischell DR, Fischell RE, Virmani R, DeVries JJ, Krucoff MW.  Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. J Am Coll Cardiol. 2006;48:2306-14.
  243. Kolodgie F, Burke A, Skorija K, Ladich E, Kutys R, Makuria AT, Virmani R.  Lipoprotein-associated phospholipase A2 Protein Expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:2523-2529.
  244. Vengrenyuk Y, Carlier S, Xanthos S, Cardoso L, Ganatos P, Virmani R, Einav S, Gilchrist L, Weinbaum S. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. PNAS. 2006 Oct;103(40):14678-14683.
  245. Manfrini O, Mont E, Leone O, Arbustini E, Eusebi V, Virmani R, Bugiardini R. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol. 2006 Jul 15;98(2):156-9.
  246. Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller S,  Coleman L, Virmani R. Experimental efficacy of an everolimus eluting cobalt  chromium stent. Catheter Cardiovasc Interv. 2006 Jul;68(1):97-103.
  247. Joner M, Finn A, Farb A, Mont E, Kolodgie F, Ladich E, Kutys R, Skorija K, Gold H, Virmani R. Pathology of drug-eluting stents in humans; delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202.
  248. Virmani R, Burke A, Farb A, Kolodgie F. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-C18.
  249. Hao H, Gabbiani G, Camenzind E, Bacchetta M, Virmani R, Bochaton-Piallat ML. Phenotypic modulcation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):326-32.
  250. Creighton W, Virmani R, Kutys R, Burke A. Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn. 2006 Feb;8(1):62-7.
  251. Virmani R, Burke AP, Kolodgie F. Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol. 2006 Feb;22 Suppl B:81B-4B.
  252. Ladich E, Virmani R, Burke A. Sudden cardiac death not related to coronary atherosclerosis. Toxicol Pathol. 2006;34(1):52-7.
  253. Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B. A novel pacilitaxel-eluting porous carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: Evaluation in a porcine model. Catheter Cardiovasc Interv 2006 Mar 30:67(3):355–502.
  254. Stefanadis C, Toutouzas K, Stefanadi E, Kolodgie F, Virmani R, Kipshidze N. First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model. Hellenic J Cardiol 2006 Jan-Feb;47(1):7-10.
  255. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy MJ, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Report (RADAR) project. J AM Coll Cardiol. 2006 Jan 3;47(1):175-81.
  256. Varga R, Eriksson M, Erdos MR, Olive M, Harten I, Kolodgie F, Capell BC, Cheng J, Faddah D, Perkins S, Avallone H, San H, Qu X, Ganesh S, Gordon LB, Virmani R, Wight TN, Nabel EG, Collins FS. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2006;103(9):3250-3255.
  257. Cooper LT, Virmani R, Chapman NM, Frustaci A, Rodeheffer RJ, Cunningham MW,McNamara DM. National Institutes of Health-Sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc. 2006;81(2):199-204.
  258. Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, Virmani R, Reutelingsperger C, Hofstra L, Narula J. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med. 2005 Dec;46(12):2051-6.
  259. Strauss BH, Segev A, Wright GA, Qiang B, Munce N, Anderson KJ, Leung G, Dick AJ, Virmani R, Butany J. Microvessels in chronic total occlusions: pathways for successful guidewire crossing? J Interv Cardiol. Microvessels in chronic total occlusions: pathways for successful guidewire crossing? J Interv Cardiol. 2005 Dec;18(6):425-36.
  260. Virmani R, Burke AP, Kolodgie F. Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol. 2006;22(Suppl B):81B-84B.
  261. Kolodgie F, Burke A, Nakazawa G, Virmani R. Is Pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thomb Vasc Biol. 2007;27:986-989.
  262. Burke A, Mont E, Kutys R, Virmani R. Left ventricular noncompaction: a pathological study of 14 cases. Human Pathology. 2005;36:403-411.
  263. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Nucl Med. 2005 Dec;46(12):2051-6.
  264. Wasserman BA, Wityk RJ, Trout HH 3rd, Virmani R. Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke. 2005 Nov;36(11):2504-13.
  265. Virmani R, Kolodgie F, Burke A, Finn A, Gold H, Tulenko T, Wrenn S, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2054-61.
  266. Kipshidze N, Sadzaglishvili K, Panarella M, Rivera EA, Virmani R, Leon MB. Evaluation of a novel endoluminal vascular occlusion device in a porcine model: early and late follow-up. J Endovasc Ther. 2005 Aug;12(4):486-94.
  267. Burke A, Creighton W, Mont E, Li L, Hogan S, Kutys R, Fowler D, Virmani R. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation. 2005 Aug 9;112(6):798-802.
  268. Blank A, Alexandrowicz G, Muchnik L, Tidhar G, Schneiderman J, Virmani R, Golan E.  Miniature self-contained intravascular magnetic resonance (IVMI) probe for clinical applications. Magn Reson Med. 2005 Jul;54(1):105-12.
  269. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005 Jul 12;112(2):270-8.